Back to Search
PAUL LANDIS, D.O.
D.O.
Emergency Medicine Physician
NPI: 1548621261IndividualAccepts Medicare
Specialties, Licenses & Credentials
Emergency Medicine PhysicianPrimary
Emergency Medicine
Code: 207P00000X
34.012982(OH)
CMS Specialties
PrimaryEMERGENCY MEDICINE
Education
OHIO UNIVERSITY, COLLEGE OF OSTEOPATHIC MEDICINE
Class of 2016
Research & Publications (20)
DNA content in the diagnostic biopsy for benign-adjacent and cancer-tissue areas predicts the need for treatment in men with T1c prostate cancer undergoing surveillance in an expectant management programme.
PMID 19678815·BJU Int·2010
8-other
PSA doubling time versus PSA velocity to predict high-risk prostate cancer: data from the Baltimore Longitudinal Study of Aging.
PMID 18614274·Eur Urol·2008
4-observational
Change in prostate cancer grade over time in men followed expectantly for stage T1c disease.
PMID 18207195·J Urol·2008
8-other
Using nuclear morphometry to predict the need for treatment among men with low grade, low stage prostate cancer enrolled in a program of expectant management with curative intent.
PMID 18085616·Prostate·2008
8-other
Prostate-specific antigen velocity risk count assessment: a new concept for detection of life-threatening prostate cancer during window of curability.
PMID 17991538·Urology·2007
8-other
Expectant management of prostate cancer with curative intent: an update of the Johns Hopkins experience.
PMID 17936806·J Urol·2007
8-other
Detection of life-threatening prostate cancer with prostate-specific antigen velocity during a window of curability.
PMID 17077354·J Natl Cancer Inst·2006
4-observational
Metabolic factors associated with benign prostatic hyperplasia.
PMID 16608892·J Clin Endocrinol Metab·2006
8-other
Delayed versus immediate surgical intervention and prostate cancer outcome.
PMID 16507832·J Natl Cancer Inst·2006
8-other
Serum testosterone and the risk of prostate cancer: potential implications for testosterone therapy.
PMID 16172240·Cancer Epidemiol Biomarkers Prev·2005
8-other
Health-related quality-of-life outcomes after anatomic retropubic radical prostatectomy in the phosphodiesterase type 5 ERA: impact of neurovascular bundle preservation.
PMID 16040103·Urology·2005
8-other
Prediagnostic plasma vitamin C levels and the subsequent risk of prostate cancer.
PMID 15925292·Nutrition·2005
8-other
Obesity does not adversely affect health-related quality-of-life outcomes after anatomic retropubic radical prostatectomy.
PMID 15913722·Urology·2005
8-other
Can a baseline prostate specific antigen level identify men who will have lower urinary tract symptoms later in life?
PMID 15879821·J Urol·2005
8-other
Nonsteroidal anti-inflammatory drugs and risk of prostate cancer in the Baltimore Longitudinal Study of Aging.
PMID 15734963·Cancer Epidemiol Biomarkers Prev·2005
8-other
Prostate-specific antigen and all-cause mortality: results from the Baltimore Longitudinal Study On Aging.
PMID 15069122·J Natl Cancer Inst·2004
8-other
Association of prostate cancer risk with insulin, glucose, and anthropometry in the Baltimore longitudinal study of aging.
PMID 14972466·Urology·2004
8-other
Can prostate specific antigen derivatives and pathological parameters predict significant change in expectant management criteria for prostate cancer?
PMID 14634395·J Urol·2003
8-other
Association of energy intake with prostate cancer in a long-term aging study: Baltimore Longitudinal Study of Aging (United States).
PMID 12597934·Urology·2003
4-observational
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1 AKRON GENERAL AVE
AKRON, OH 44307 - Phone
- (330) 344-6000
Quick Facts
- NPI
- 1548621261
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 10
- Publications
- 20
Are you this provider?
Claim Your Profile